A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT05369286 · UNKNOWN
Trial details
- NCT number
- NCT05369286
- Sponsor
- Maxinovel Pty., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-05-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.